The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
Big drugmakers aren’t doing as big deals as they had, mostly doing less risky bolt-ons under $10 billion. on.wsj.com/4dhCdrG https://on.wsj.com/4dhCdrG
2026-03-31T23:20:45.157Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.